Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Giles

Showing results (191-200 of 676) with videos related to

Pageof 68
Sort By:
Leukemia & Lymphoma|January 1, 1997
Serum levels of TNF, IL-6 and sCD23 correlate with changes in lymphocyte count in patients with B-cell chronic lymphocytic leukaemia receiving interferon-alpha therapyA P Jewell, C P Worman, F J Giles, et al.
Journal of the Canadian Association of Radiologists|September 1, 1984
Canadian diagnostic radiology manpower 1982D W MacEwan, T J Giles, E L Lansdown, et al.
Oncotarget|September 17, 2017
Pseudoprogression in microsatellite instability-high colorectal cancer during treatment with combination T cell mediated immunotherapy: a case report and literature reviewYoung Kwang Chae, Si Wang, Halla Nimeiri, et al.
Scandinavian Journal of Rheumatology|March 10, 2017
Impact of biological treatment on left ventricular function and morphology in rheumatoid arthritis patients without cardiac symptoms, assessed by cardiac magnetic resonance imagingY Kobayashi, H Kobayashi, J Giles, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 5, 2003
Pattern of gene expression and immune responses to Semenogelin 1 in chronic hematologic malignanciesYana Zhang, Zhiqing Wang, Haichao Liu, et al.
Carcinogenesis|January 29, 2013
The yin and yang of nitric oxide in cancer progressionAmy J Burke, Francis J Sullivan, Francis J Giles, et al.
BMJ Quality & Safety|March 1, 2013
Developing a patient measure of safety (PMOS)Sally J Giles, Rebecca J Lawton, Ikhlaq Din, et al.
Cancer|October 24, 2000
Therapeutic choices in younger patients with chronic myelogenous leukemiaH M Kantarjian, F J Giles, S O'Brien, et al.
Hematology/Oncology Clinics of North America|July 24, 2004
Accelerated and blastic phases of chronic myelogenous leukemiaFrancis J Giles, Jorge E Cortes, Hagop M Kantarjian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeuticsAlain C Mita, Monica M Mita, Steffan T Nawrocki, et al.
Pageof 68

Showing results (191-200 of 676) with videos related to

Sort By:
Pageof 68
Leukemia & Lymphoma|January 1, 1997
Serum levels of TNF, IL-6 and sCD23 correlate with changes in lymphocyte count in patients with B-cell chronic lymphocytic leukaemia receiving interferon-alpha therapyA P Jewell, C P Worman, F J Giles, et al.
Journal of the Canadian Association of Radiologists|September 1, 1984
Canadian diagnostic radiology manpower 1982D W MacEwan, T J Giles, E L Lansdown, et al.
Oncotarget|September 17, 2017
Pseudoprogression in microsatellite instability-high colorectal cancer during treatment with combination T cell mediated immunotherapy: a case report and literature reviewYoung Kwang Chae, Si Wang, Halla Nimeiri, et al.
Scandinavian Journal of Rheumatology|March 10, 2017
Impact of biological treatment on left ventricular function and morphology in rheumatoid arthritis patients without cardiac symptoms, assessed by cardiac magnetic resonance imagingY Kobayashi, H Kobayashi, J Giles, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 5, 2003
Pattern of gene expression and immune responses to Semenogelin 1 in chronic hematologic malignanciesYana Zhang, Zhiqing Wang, Haichao Liu, et al.
Carcinogenesis|January 29, 2013
The yin and yang of nitric oxide in cancer progressionAmy J Burke, Francis J Sullivan, Francis J Giles, et al.
BMJ Quality & Safety|March 1, 2013
Developing a patient measure of safety (PMOS)Sally J Giles, Rebecca J Lawton, Ikhlaq Din, et al.
Cancer|October 24, 2000
Therapeutic choices in younger patients with chronic myelogenous leukemiaH M Kantarjian, F J Giles, S O'Brien, et al.
Hematology/Oncology Clinics of North America|July 24, 2004
Accelerated and blastic phases of chronic myelogenous leukemiaFrancis J Giles, Jorge E Cortes, Hagop M Kantarjian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeuticsAlain C Mita, Monica M Mita, Steffan T Nawrocki, et al.
Pageof 68